Back to RecallTracker
Health Canada Medical devices

BD BBL Sensi Disc Ampicillin 2 Μg (AM-2)

Issued November 20, 2024
Issue
BD identified through potency test, as part of special stability test requests to monitor Ampicillin AM-2, unsatisfactory results of 65% at 18 months. The potency acceptance criteria is 80-140% and product shelf life is 24 months. A retest with control batch and extended sampling confirmed the low potency results. Recall Start Date: November 6, 2024
Hazard description
Performance
Product
Product name
BD BBL Sensi Disc Ampicillin 2 Μg (AM-2)
Reference
ID
RA-76548